US Biologic Broadens Intellectual Property Platform in Prevention of Zoonotic Disease

US Biologic, a leading oral vaccine and therapeutic delivery company, today announced that the United States Patent and Trademark Office has issued U.S. Patent #1065360 entitled “Composition & Method for Reducing Zoonotic Infectious Diseases.” The patent extends the US Biologic OrisBio^™ oral-delivery technology platform in the creation of orally delivered vaccines.